“… Animal model | Key features | Behavioral characteristics of model | BD patterns | References |
Pharmacological |
Amphetamine (AMPH) | Acute/chronic peripheral administration | ↑ locomotor activity related to DA, some evidence for cycling from depression | Mania + cycling (?) | [ 88 – 95 ] |
Cocaine | Chronic peripheral administration | ↑ locomotor activity related to DA, time-dependent sensitization | Mania + cycling (?) | [ 96 ] |
Fenproporex | Converted to AMPH in vivo, acute and chronic peripheral administration | ↑ locomotor activity | Mania | [ 97 ] |
GBR 12909, an inhibitor of the DA transporter (DAT) | Acute peripheral administration | ↑ activity and perseverative patterns of locomotion for several hours | Mania | [ 98 ] |
Ouabain | Acute icv administration | ↑ activity, ↓ reversal learning | Mania | [ 99 – 101 ] |
Environmental |
Sleep deprivation | Sleep deprivation (SD) using the platform method with testing afterwards, vary duration and frequency of SD | After sleep deprivation: ↑ activity, insomnia, ↑ irritability, ↑ aggression, ↑ sexual behavior, evidence of sensitization to repeated SD | Mania | [ 102 , 103 ,] |
Genetically selected strains |
Black Swiss mice | Mania-like phenotype observed in mice from Taconic Biosciences but not Charles River Labs | Hyperactive, ↓ immobility in FST, ↑ response to AMPH, ↑ aggression, ↑ saccharin preference | Mania | [ 104 ] |
Hyperactive (HYPER) rat | Derived from a single litter of Sprague–Dawley rats that were discovered to be hyperactive at night. |
…”